Farzan Nima 4
4 · Kinnate Biopharma Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 4
Farzan Nima
DirectorPresident and CEO
Transactions
- Award
Employee stock option (right to buy)
2021-02-12+275,000→ 275,000 totalExercise: $35.38Exp: 2031-02-12→ Common Stock (275,000 underlying)
Footnotes (1)
- [F1]The Option vests and becomes exercisable over time at the following rate: 1/48th of the total number of shares subject to the Option shall vest each month in equal installments starting on March 1, 2021.